Gamida Cell Ltd. (GMDA) Financials

GMDA Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 117.7 million 117.4 million
June 30, 2023 112.5 million 138.2 million
March 31, 2023 105.1 million 120.5 million
Dec. 31, 2022 124.8 million 132.8 million

GMDA Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -18.6 million 1.4 million
June 30, 2023 -22.0 million 1.4 million
March 31, 2023 -23.1 million 1.5 million
Dec. 31, 2022 -19.7 million 1.2 million

GMDA Net Income

No data available :(

GMDA Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 60.4 million - 3.8 million
June 30, 2023 54.1 million - 4.6 million
March 31, 2023 46.8 million - 5.1 million
Dec. 31, 2022 64.7 million - 7.5 million

GMDA Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 151.9 million
June 30, 2023 102.2 million
March 31, 2023 76.8 million
Dec. 31, 2022 63.8 million

GMDA Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 12000 4.2 million 13.8 million -
June 30, 2023 6000 8.7 million 6.3 million 3862
March 31, 2023 827000 8.8 million 5.2 million 5576
Dec. 31, 2022 3.5 million 11.0 million 6.5 million -2.8 million

GMDA Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 673000 626000
June 30, 2023 - 108000
March 31, 2023 - 106000
Dec. 31, 2022 - 49000

GMDA

Price: $0.03

52 week price:
0.01
2.51

Earnings Per Share: -0.82 USD

P/E Ratio: -0.47

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 182493

Market Capitalization: 4.3 million

Links: